EDITED BY TRACY YOCHUM, MCCLATCHY COMMERCE We might earn a commission if you make a purchase through one of the links. The McClatchy/Merced Sun-Star Commerce Content team, which is independent from ...
Enrollment on track in registrational Phase 2 portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type advanced solid tumors; more than 75 ...